165 related articles for article (PubMed ID: 23563494)
1. Antiphospholipid antibodies in children with systemic lupus erythematosus: a long-term clinical and laboratory follow-up status study from northwest India.
Ahluwalia J; Singh S; Naseem S; Suri D; Rawat A; Gupta A; Masih J; Bose S
Rheumatol Int; 2014 May; 34(5):669-73. PubMed ID: 23563494
[TBL] [Abstract][Full Text] [Related]
2. Pattern of disease expression in SLE patients with antiphospholipid antibodies: data from Indian Systemic Lupus Erythematosus Inception cohort (INSPIRE).
Shobha V; Rajasekhar L; Manuel S; Nayana V; Kavadichanda C; Kounassegarane D; Mathew AJ; Gupta R; Rathi M; Ghosh P; Tripathy SR; Das B; Selvam S; Singh AK; Singh A; Jain A; Aggarwal A
Rheumatol Int; 2024 May; 44(5):819-829. PubMed ID: 38082159
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India.
Singh S; Gupta MK; Ahluwalia J; Singh P; Malhi P
Rheumatol Int; 2009 Oct; 29(12):1455-61. PubMed ID: 19306097
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid antibodies in children with systemic lupus erythematosus: a prospective study in northern India.
Ahluwalia J; Singh S; Garewal G
Rheumatol Int; 2005 Sep; 25(7):530-5. PubMed ID: 15338189
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.
Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S
Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus.
Male C; Foulon D; Hoogendoorn H; Vegh P; Silverman E; David M; Mitchell L
Blood; 2005 Dec; 106(13):4152-8. PubMed ID: 16144797
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population.
Dayama A; Dass J; Mahapatra M; Saxena R
Clin Appl Thromb Hemost; 2017 Sep; 23(6):657-662. PubMed ID: 27067744
[TBL] [Abstract][Full Text] [Related]
8. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antiphospholipid antibodies in patients with subacute and chronic cutaneous lupus erythematosus.
García-Martín P; García-García C; Fraga J; García-Díez A
Actas Dermosifiliogr; 2013 Apr; 104(3):232-8. PubMed ID: 23332556
[TBL] [Abstract][Full Text] [Related]
12. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
Mustonen P; Lehtonen KV; Javela K; Puurunen M
Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
[TBL] [Abstract][Full Text] [Related]
13. Anti-RNP/Sm antibodies in patients with systemic lupus erythematosus and its role in thrombosis: a case-control study.
Zamora-Medina MDC; Hinojosa-Azaola A; Nuñez-Alvarez CA; Vargas-Ruiz AG; Romero-Diaz J
Clin Rheumatol; 2019 Mar; 38(3):885-893. PubMed ID: 30515663
[TBL] [Abstract][Full Text] [Related]
14. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies.
Horbach DA; van Oort E; Donders RC; Derksen RH; de Groot PG
Thromb Haemost; 1996 Dec; 76(6):916-24. PubMed ID: 8972011
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, persistence and clinical correlations of classic and novel antiphospholipid antibodies in systemic lupus erythematosus.
Marchetti T; Ribi C; Perneger T; Trendelenburg M; Huynh-Do U; de Moerloose P; Chizzolini C
Rheumatology (Oxford); 2018 Aug; 57(8):1350-1357. PubMed ID: 29672737
[TBL] [Abstract][Full Text] [Related]
16. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study.
Berube C; Mitchell L; Silverman E; David M; Saint Cyr C; Laxer R; Adams M; Vegh P; Andrew M
Pediatr Res; 1998 Sep; 44(3):351-6. PubMed ID: 9727712
[TBL] [Abstract][Full Text] [Related]
17. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A
Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815
[TBL] [Abstract][Full Text] [Related]
18. [Antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus].
Formiga F; Moga I; Canet R; Pac M; Mitjavila F; Pujol R
Rev Clin Esp; 1996 Nov; 196(11):734-6. PubMed ID: 9132835
[TBL] [Abstract][Full Text] [Related]
19. Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.
İlgen U; Yayla ME; Ateş A; Okatan İE; Yurteri EU; Torgutalp M; Keleşoğlu ABD; Turgay TM; Kınıklı G
Lupus; 2018 Apr; 27(4):665-669. PubMed ID: 29050535
[TBL] [Abstract][Full Text] [Related]
20. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
